PMID- 28911142 OWN - NLM STAT- MEDLINE DCOM- 20171012 LR - 20181208 IS - 1945-7197 (Electronic) IS - 0021-972X (Print) IS - 0021-972X (Linking) VI - 102 IP - 9 DP - 2017 Sep 1 TI - Deficient Endogenous Glucose Production During Exercise After Total Pancreatectomy/Islet Autotransplantation. PG - 3288-3295 LID - 10.1210/jc.2017-00923 [doi] AB - CONTEXT: Total pancreatectomy followed by intrahepatic islet autotransplantation (TP/IAT) is performed to alleviate severe, unrelenting abdominal pain caused by chronic pancreatitis, to improve quality of life, and to prevent diabetes. OBJECTIVE: To determine the cause of exercise-induced hypoglycemia that is a common complaint in TP/IAT recipients. DESIGN: Participants completed 1 hour of steady-state exercise. SETTING: Hospital research unit. PATIENTS AND OTHER PARTICIPANTS: We studied 14 TP/IAT recipients and 10 age- and body mass index-matched control subjects. INTERVENTIONS: Peak oxygen uptake (VO2) was determined via a symptom-limited maximal cycle ergometer test. Fasted subjects then returned for a primed [6,6-2H2]-glucose infusion to measure endogenous glucose production while completing 1 hour of bicycle exercise at either 40% or 70% peak VO2. MAIN OUTCOME MEASURES: Blood samples were obtained to measure glucose metabolism and counterregulatory hormones before, during, and after exercise. RESULTS: Although the Borg Rating of Perceived Exertion did not differ between recipients and control subjects, aerobic capacity was significantly higher in controls than in recipients (40.4 +/- 2.0 vs 27.2 +/- 1.4 mL/kg per minute; P < 0.001). This difference resulted in workload differences between control subjects and recipients to reach steady-state exercise at 40% peak VO2 (P = 0.003). Control subjects significantly increased their endogenous glucose production from 12.0 +/- 1.0 to 15.2 +/- 1.0 micromol/kg per minute during moderate exercise (P = 0.01). Recipients did not increase endogenous glucose production during moderate exercise (40% peak VO2) but succeeded during heavy exercise, from 10.1 +/- 0.4 to 14.8 +/- 2.0 micromol/kg per minute (70% peak VO2; P = 0.001). CONCLUSIONS: Failure to increase endogenous glucose production during moderate exercise may be a key contributor to the hypoglycemia TP/IAT recipients experience. CI - Copyright (c) 2017 Endocrine Society FAU - Bogachus, Lindsey D AU - Bogachus LD AD - Pacific Northwest Diabetes Research Institute, Seattle, Washington 98122. AD - Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, Washington 98195. FAU - Oseid, Elizabeth AU - Oseid E AD - Pacific Northwest Diabetes Research Institute, Seattle, Washington 98122. FAU - Bellin, Melena AU - Bellin M AD - Division of Diabetes, Endocrinology, and Metabolism, Department of Medicines and Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455. FAU - Vella, Adrian AU - Vella A AD - Division of Endocrinology, Diabetes, and Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota 55905. FAU - Robertson, R Paul AU - Robertson RP AD - Pacific Northwest Diabetes Research Institute, Seattle, Washington 98122. AD - Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, Washington 98195. AD - Division of Diabetes, Endocrinology, and Metabolism, Department of Medicines and Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455. LA - eng GR - R01 DK078646/DK/NIDDK NIH HHS/United States GR - TL1 TR000422/TR/NCATS NIH HHS/United States GR - KL2 TR002317/TR/NCATS NIH HHS/United States GR - KL2 TR000421/TR/NCATS NIH HHS/United States GR - UL1 TR000423/TR/NCATS NIH HHS/United States GR - T32 DK007203/DK/NIDDK NIH HHS/United States PT - Journal Article PL - United States TA - J Clin Endocrinol Metab JT - The Journal of clinical endocrinology and metabolism JID - 0375362 RN - 0 (Blood Glucose) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Adult MH - Blood Glucose/analysis MH - Case-Control Studies MH - Exercise/*physiology MH - Exercise Tolerance/*physiology MH - Female MH - Follow-Up Studies MH - Glucose/*metabolism MH - Heart Rate/physiology MH - Humans MH - Islets of Langerhans Transplantation/*methods MH - Male MH - Oxygen Consumption/physiology MH - Pancreatectomy/*methods MH - Pancreatitis, Chronic/diagnosis/*surgery MH - Risk Assessment MH - Sampling Studies PMC - PMC5587075 EDAT- 2017/09/16 06:00 MHDA- 2017/10/13 06:00 PMCR- 2018/09/01 CRDT- 2017/09/16 06:00 PHST- 2017/04/18 00:00 [received] PHST- 2017/06/06 00:00 [accepted] PHST- 2017/09/16 06:00 [entrez] PHST- 2017/09/16 06:00 [pubmed] PHST- 2017/10/13 06:00 [medline] PHST- 2018/09/01 00:00 [pmc-release] AID - 3920533 [pii] AID - jcem_201700923 [pii] AID - 10.1210/jc.2017-00923 [doi] PST - ppublish SO - J Clin Endocrinol Metab. 2017 Sep 1;102(9):3288-3295. doi: 10.1210/jc.2017-00923.